BETHESDA, Maryland, May 26 /PRNewswire/ --

New Health Sciences Inc. (NHSi) has won a two-year award of US$1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a groundbreaking blood-storage system.

The project aims to develop the Hemanext Anaerobic Storage Platform, which delivers higher quality blood for transfusion therapy and extends the shelf life of blood for transfusion.

NHSi has demonstrated that this new technology can deliver higher-quality, more physiologic blood, with an improved capacity to deliver oxygen and more deformable red blood cells for better capillary perfusion, and extend by 50 percent or more the shelf life of stored red blood cells.

BILLERICA, Massachusetts, May 26 /PRNewswire/ --

Businesses are drowning in a sea of audit log data from their IT systems, which must be tracked to mitigate the risks of security threats, legal exposure and regulatory compliance. Vertica is working with Italian IT security specialist, Integra, to offer these businesses the world's fastest log warehouse for managing never-ending volumes of audit data.

HAMBURG, Germany, May 26 /PRNewswire/ -- The fact that successful viral advertising doesn't always have to come from the USA or England has been impressively demonstrated recently by the Hamburg ad agency GrabarzPartner for its client Bontrust. Two weeks ago the agency uploaded a 75-second spot for the investment consulting firm on the video sharing website YouTube. The lavishly produced film shows a world that is completely made of banknotes, and in which the Abraham Lincoln immortalized on dollar bills falls head over heels in love with a female banknote and fathers children with her. Ending: Make your money multiply with us.

SAN JOSE, California, May 26 /PRNewswire/ --

- maXTouch represents the market's most advanced Touchscreen Technology for Mobile Phones, Netbooks and other Electronic Devices

Atmel(R) Corporation (Nasdaq: ATML) announced today a new fully integrated capacitive touchscreen technology - maXTouch(TM) - providing touchscreen performance which significantly exceeds today's leading edge solutions. Atmel's patented capacitive touch technology combined with an optimized and touch-sensing enabled AVR(R) microcontroller provide unlimited touch capability, the fastest response times and the highest acquisition precision.

WELLESLEY HILLS, Massachusetts, May 26 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. (Finn), announced today that there has been promising initial interest from pharma companies in the intellectual property of Prospect Therapeutics, Inc. (Prospect).

In preclinical studies, GCS-100 inhibited blood vessel formation in a variety of cancer models. Development and growth of solid tumors requires new blood vessel growth, or angiogenesis, to deliver oxygen and nutrients to a tumor. Galectin-3 also plays an important role in stimulating angiogenesis in a variety of tissues.

The intellectual property, regulatory dossier, fixed assets and clinical inventory will be sold at auction on Monday, June 29, 2009 at 12:00 noon.

NEW YORK, May 26 /PRNewswire/ --

- TED Fellows program brings outstanding, world-changing leaders to participate in TED community

Organizers of the TED Conference introduced today the 25 new TED Fellows who will participate in TED's annual international conference, TEDGlobal. These Fellows have been invited to join the TED community by attending TEDGlobal 2009, to be held in Oxford, UK, July 21-24. The 25 TEDGlobal Fellows join the 40 TED Fellows selected for the TED2009 Conference, held in February in Long Beach, where the TED Fellows program was announced. The principal goal of the TED Fellows program is to empower TED Fellows to effectively communicate their work to the TED community and to the world.

HUNTINGTON BEACH, California and AMSTERDAM, May 26 /PRNewswire/ --

- Agendia Increases U.S. Footprint with Domestic Executive Team and Operations

Agendia, a world leader in molecular cancer diagnostics, today announced the opening of its U.S. clinical genomics laboratory in Huntington Beach, CA. The laboratory is fully-licensed and compliant with the Clinical Laboratory Improvements Amendments (CLIA) as administered by the Centers for Medicare and Medicaid Services (CMS).

LONDON, May 26 /PRNewswire/ --

- Gyration Air Mouse(TM) GO Plus With MotionSense(TM) Now Available in UK

LONDON, May 26 /PRNewswire/ --

- Sri Lanka Operator Adopts GSMA's Carrier ENUM Technology to Offer Subscribers a Variety of new, Cost-Efficient IP-Based Services

LONDON, May 26 /PRNewswire/ --

PARIS, May 26 /PRNewswire/ --

- Next Generation Emergency Contraceptive Will First be Launched in UK, Germany and France as Company Expands International Operations

HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate), its next generation emergency contraceptive, has been granted marketing authorization by the European Commission. The unanimous decision by all member states enables HRA Pharma to begin marketing ellaOne throughout the European Union, making it the only approved product to have been specifically designed and developed for use as an emergency contraceptive.